Arbutus Biopharma (ABUS) vs Adlai Nortye Group (ANL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Adlai Nortye Group (ANL) has outperformed Arbutus Biopharma (ABUS) over the past year, gaining 712.1% versus a gain of 0.0%. Adlai Nortye Group is the larger company by market cap ($904.8 million vs $657.6 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABUS | ANL |
|---|---|---|
| Share price | $4.29 | $14.05 |
| Market cap | $657.55M | $904.79M |
| 1-day change | -4.24% | -2.84% |
| YTD return | -10.81% | +889.44% |
| 1-year return | 0.00% | +712.14% |
| 5-year return | +5.15% | — |
| P/E ratio (TTM) | 5.43 | — |
| EPS (TTM) | $0.79 | $-0.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.45 | $17.25 |
| 52-week low | $3.50 | $0.879 |
| Distance from 52-week high | -21.28% | -18.55% |
| Average volume | 4.65M | 179.55K |
| Shares outstanding | 153.28M | 58.73M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANL has outperformed ABUS by 712.1 percentage points over the past year.
ABUS vs ANL FAQ
Which is bigger, Arbutus Biopharma or Adlai Nortye Group?
Adlai Nortye Group (ANL) is larger, with a market capitalization of $904.79M compared with $657.55M for Arbutus Biopharma (ABUS).
Which stock has performed better over the past year, ABUS or ANL?
ANL returned +712.14% over the past 12 months, compared with 0.00% for ABUS (price return, excluding dividends). Past performance does not predict future results.
Are Arbutus Biopharma and Adlai Nortye Group in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.